KCNA2

Last updated

KCNA2
Protein KCNA2 PDB 1dsx.png
Identifiers
Aliases KCNA2 , HBK5, HK4, HUKIV, KV1.2, MK2, NGK1, RBK2, EIEE32, potassium voltage-gated channel subfamily A member 2, DEE32
External IDs OMIM: 176262; MGI: 96659; HomoloGene: 21034; GeneCards: KCNA2; OMA:KCNA2 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001204269
NM_004974

NM_008417

RefSeq (protein)

NP_001191198
NP_004965

NP_032443

Location (UCSC) Chr 1: 110.52 – 110.63 Mb Chr 3: 107.01 – 107.02 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Potassium voltage-gated channel subfamily A member 2 also known as Kv1.2 is a protein that in humans is encoded by the KCNA2 gene. [5] [6]

Contents

Function

Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. Four sequence-related potassium channel genes - shaker, shaw, shab, and shal - have been identified in Drosophila, and each has been shown to have human homolog(s). This gene encodes a member of the potassium channel, voltage-gated, shaker-related subfamily. This member contains six membrane-spanning domains with a shaker-type repeat in the fourth segment. It belongs to the delayed rectifier class, members of which allow nerve cells to efficiently repolarize following an action potential. The coding region of this gene is intronless, and the gene is clustered with genes KCNA3 and KCNA10 on chromosome 1. [6]

Interactions

KCNA2 has been shown to interact with KCNA4, [7] DLG4, [8] PTPRA, [9] KCNAB2, [7] [10] RHOA [11] and Cortactin. [12]

Clinical significance

Mutations in this gene cause KCNA2-related neurological disorders. These can include epilepsy, intellectual and developmental disabilities, movement disorders, autism spectrum disorder, attention deficit hyperactivity disorder, and hereditary spastic paraplegia [13] [14] .

See also

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000177301 Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000040724 Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. Gutman GA, Chandy KG, Grissmer S, Lazdunski M, McKinnon D, Pardo LA, et al. (December 2005). "International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels". Pharmacological Reviews. 57 (4): 473–508. doi:10.1124/pr.57.4.10. PMID   16382104. S2CID   219195192.
  6. 1 2 "Entrez Gene: KCNA2 potassium voltage-gated channel, shaker-related subfamily, member 2".
  7. 1 2 Coleman SK, Newcombe J, Pryke J, Dolly JO (August 1999). "Subunit composition of Kv1 channels in human CNS". Journal of Neurochemistry. 73 (2): 849–858. doi: 10.1046/j.1471-4159.1999.0730849.x . PMID   10428084.
  8. Eldstrom J, Doerksen KW, Steele DF, Fedida D (November 2002). "N-terminal PDZ-binding domain in Kv1 potassium channels". FEBS Letters. 531 (3): 529–537. Bibcode:2002FEBSL.531..529E. doi:10.1016/S0014-5793(02)03572-X. PMID   12435606. S2CID   40689829.
  9. Tsai W, Morielli AD, Cachero TG, Peralta EG (January 1999). "Receptor protein tyrosine phosphatase alpha participates in the m1 muscarinic acetylcholine receptor-dependent regulation of Kv1.2 channel activity". The EMBO Journal. 18 (1): 109–118. doi:10.1093/emboj/18.1.109. PMC   1171107 . PMID   9878055.
  10. Nakahira K, Shi G, Rhodes KJ, Trimmer JS (March 1996). "Selective interaction of voltage-gated K+ channel beta-subunits with alpha-subunits". The Journal of Biological Chemistry. 271 (12): 7084–7089. doi: 10.1074/jbc.271.12.7084 . PMID   8636142.
  11. Cachero TG, Morielli AD, Peralta EG (June 1998). "The small GTP-binding protein RhoA regulates a delayed rectifier potassium channel". Cell. 93 (6): 1077–1085. doi: 10.1016/S0092-8674(00)81212-X . PMID   9635436. S2CID   13943167.
  12. Hattan D, Nesti E, Cachero TG, Morielli AD (October 2002). "Tyrosine phosphorylation of Kv1.2 modulates its interaction with the actin-binding protein cortactin". The Journal of Biological Chemistry. 277 (41): 38596–38606. doi: 10.1074/jbc.M205005200 . PMID   12151401.
  13. Helbig KL, Hedrich UB, Shinde DN, Krey I, Teichmann AC, Hentschel J, et al. (October 2016). "A recurrent mutation in KCNA2 as a novel cause of hereditary spastic paraplegia and ataxia". Annals of Neurology. 80 (4) ana.24762: 638–642. doi:10.1002/ana.24762. PMC   5129488 . PMID   27543892.
  14. Xie C, Kessi M, Yin F, Peng J (November 2024). "Roles of KCNA2 in Neurological Diseases: from Physiology to Pathology". Molecular Neurobiology. 61 (11): 8491–8517. doi:10.1007/s12035-024-04120-9. PMID   38517617.

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.